A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers
- 1 June 1990
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 5 (6), 609-618
- https://doi.org/10.1002/jbmr.5650050610
Abstract
The effects of recombinant human growth hormone (rhGH) on biochemical markers of bone turnover and bone mineral content (BMC) were investigated in 20 normal male volunteers (aged 22‐31 years) randomized to treatment for 7 days with either rhGH (0.1 IU/kg subcutaneously twice a day) or placebo. Serum somatomedin C rose during treatment (p < 0.001) but was not significantly different from baseline at day 14. The fasting urinary hydroxyproiine/creatinine (p < 0.001) and calcium/creatinine ratios (p < 0.01) increased during treatment and remained elevated for 4 and 2 weeks, respectively. Serum bone 7‐carboxyglutamic acid‐containing protein (BGP) increased during treatment (p < 0.001) and remained elevated for 6 months (p < 0.02). Serum bone alkaline phosphatase (B‐AP), after an initial fall in the treatment period (p < 0.001), increased slightly in the following months (p < 0.01). In the rhGH group BMC was significantly higher than the prestudy value at day 14 (p < 0.05) but was unaltered at the end of study. The simultaneous increase in markers of bone resorption and formation during rhGH treatment followed by a decline in resorption parameters within a few weeks and the prolonged effect on BGP and B‐AP demonstrate that rhGH treatment stimulates osteoblasts and activates bone remodeling.Keywords
Funding Information
- Nordisk Gentofte A/S
This publication has 53 references indexed in Scilit:
- Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor IBiochemical and Biophysical Research Communications, 1988
- AN OPEN‐LABELLED STUDY OF THE SAFETY, ACUTE METABOLIC ACTIVITY AND PHARMACOKINETIC PROFILE OF A SHORT‐TERM COURSE OF RECOMBINANT HUMAN GROWTH HORMONE IN HEALTHY VOLUNTEERSClinical Endocrinology, 1987
- Trabecular bone remodeling and bone balance in hyperthyroidismBone, 1985
- Reconstruction of the resorptive site in iliac trabecular bone: A kinetic model for bone resorption in 20 normal individualsMetabolic Bone Disease and Related Research, 1984
- BIOSYNTHETIC METHIONYL HUMAN GROWTH HORMONE IS BIOLOGICALLY ACTIVE IN ADULT MANThe Lancet, 1982
- Growth hormone: the effect on skeletal renewal in the adult dog I. Morphometric studiesCalcified Tissue International, 1972
- Observations on the responsiveness of human subjects to human growth hormoneJCI Insight, 1971
- Tetracycline-based histological analysis of bone remodelingCalcified Tissue International, 1969
- The assessment of phosphate reabsorptionClinica Chimica Acta; International Journal of Clinical Chemistry, 1969
- Suggested Sequential Mode of Control of Changes in Cell Behaviour in Adult Bone RemodellingNature, 1965